Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $12.54, but opened at $11.7350. Ambu A/S shares last traded at $11.7350, with a volume of 500 shares traded.
Ambu A/S Stock Performance
The stock has a 50 day moving average price of $13.28 and a two-hundred day moving average price of $14.25. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67. The company has a market capitalization of $2.76 billion, a price-to-earnings ratio of 37.85 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%. The firm had revenue of $242.85 million during the quarter.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Read More
- Five stocks we like better than Ambu A/S
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
